Senate Hearing on Pandemic Discusses Reshoring Pharma, PPE
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
Elizabeth Warren Gets it Right on Pharmaceutical Manufacturing
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
CPA Conference Final Day: On China, Rubio And Posey Go Hard
Three members of Congress representing both parties are writing legislation to help domestic enterprises post-pandemic.
CPA Conference Day 1: Making Generic Pharmaceuticals A National Security Imperative
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.
What About A ‘Country of Origin’ Label for Pharmaceuticals?
By Kenneth Rapoza, CPA Industry Analyst The FDA hasn’t inspected nearly 1,000 overseas labs making drugs for the US market due to the pandemic. But
America’s Dependence on China for Essential Medicines a Growing Safety Threat
Rosemary Gibson chairs the healthcare committee of the Coalition for a Prosperous America. She is the author of “China Rx: Exposing the Risks of America’s
FDA Releases Massive List of Essential Medicines That Should Be Made In USA
By Kenneth Rapoza, CPA Industry Analyst Score one for the local pharmaceutical industry. FDA’s essential medicine and critical inputs list gives domestic producers a a
Heparin Shortages Due to a Dependence on China. Why American Cattle is the Solution.
By Kenneth Rapoza, CPA Industry Analyst Why are we dependent on China’s pig population for a critical animal source material used in making heparin? Bovine
The U.S. needs to support American-made medicines
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
Industry Analysis: Securing USA Made PPE Before the Next Health Crisis
By Kenneth Rapoza, CPA Industry Analyst Summary: If we experience a global pandemic like this again, we know two things to be true: we can’t
